HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 10, October 2020 – Artificial Intelligence Technologies — Helping the Fight Against COVID-19s       » Improving Sensitivity of Optical Receivers for Space Communication       » Genetic Variants Identified for the Susceptibility to Neuroblastoma       » Novo Nordisk Launches New Treatment for Diabetes in Singapore       » SMART Researchers Find New Way to Make Bacteria More Sensitive to Antibiotics       » Study Finds Liver Injury to be Common Among COVID-19 Patients      
NEWS CRUNCH
NTU scientists use dead bacteria to kill colorectal cancer cells

Colorectal cancer is the number one cancer in Singapore and the third most commonly occurring cancer in the world. It is characterised by the uncontrolled growth of cells in the epithelial tissue of the large intestine. Like other cancers, treatment options for colorectal cancer haven't changed much over the years and is still restricted to chemotherapy, radiotherapy and surgery.

In a news release issued on Monday (Nov 9), NTU said that a team led by Professor Teoh Swee Hin harnessed the Clostridium sporogenes (C. sporogenes) bacteria in its dead form, and its secretions, to effectively destroy colon tumour cells.

In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74 per cent. The team tested the secretions harvested from a live bacteria culture and these secretions reduced the growth of colon tumour cells by as much as 83 per cent.

NTU said that traditional cancer treatments like chemotherapy and radiotherapy do not work well in the colon due to reduced blood flow and lack of oxygen and nutrient flow. It said that these therapies use oxygen molecules to damage the DNA of cancer cells and rely on blood flow to transport therapeutic drugs to the tumour. The team conducted the experiments in artificially-created environments resembling the inside of a human body, rather than on a flat surface in a petri-dish.

"In contrast, the NTU team showed that dead C. sporogenes bacteria can kill tumour cells in an oxygen-starved tumour microenvironment," said NTU.

"We found that even when the C. sporogenes bacteria is dead, its natural toxicity continues to kill cancer cells, unlike the conventional chemotherapy drugs which need oxygen to work," explained Prof Teoh.

Prof Teoh said that other research groups have experimented with live bacteria to destroy cancer cells, but this treatment posed a risk of infection as live bacteria will grow and proliferate.

"In the NTU study, as the bacteria were already killed by heat, there was no risk of the bacteria multiplying and causing more harm than the desired dose meant to kill colorectal cancer cells."

Professor James Best, Dean of NTU's Lee Kong Chian School of Medicine, said: "This is a significant discovery that potentially opens a new avenue to tackle this very common cancer, which is difficult to treat after it has spread. While it is early days, this exciting research finding provides hope of a new treatment option for millions of people affected by bowel cancer each year."

This study was published in the journal Scientific Reports in October: https://www.nature.com/articles/srep15681

NEWS CRUNCH  
news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy